Safety and Pharmacology Study of SNX-5422 in Subjects With Refractory Solid Tumor Malignancies
Clinical trial NCT01611623 · COMPLETED
Trial details
- NCT number
- NCT01611623
- Sponsor
- Esanex Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-05-01
- Primary completion
- 2012-11-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.